// App-Quantinova.ai

AB0487 : ANTIPHOSPHOLIPID SYNDROME AND EPILEPSY: WHERE DO WE STAND?

Researchers

Presenter

  • M.A. Noureldine

Principal Investigators

  • G. Harifi

  • A.A. Haydar

  • A. Berjawi

  • M. Nader

  • R. Elnawar

  • A. Sweid

  • J. Al Saleh

  • M.A. Khamashta

  • I. Uthman

Medical Centers

  • Lupus Research Unit, The Rayne Institute, Division of Wome-s Health, St Thomas Hospital, London, United Kingdom

  • Department of Rheumatology, Dubai Hospital, Dubai, United Arab Emirates

  • Division of Rheumatology, American University of Beirut, Beirut, Lebanon

  • Dept. de Neurologie, Universite Paris Diderot, Paris, France

  • Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon

  • Dept. of Neurosurgery, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon

  • Dept. of Neurosurgery, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon

Locations

  • France

  • United Kingdom

  • Lebanon

  • United Arab Emirates

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Antiphospholipid syndrome

  • Thrombocytopenia

  • Venous thrombosis

  • Epilepsy

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved